Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 5/20 | 0.54 |
| ▸ | DRD2 | P14416 | 2/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | DRD3 | P35462 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9485679 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL1260665 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL1262348 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL1262236 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL3453399 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL1260761 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL9005868 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL11359571 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL9005882 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 | |
| SCHEMBL9485273 | 1.00 | KCNH2 (0.66) | KCNH2MAPTBCHEDRD2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2024-07-16 | — | — | US | disclosed |
| CN-112195474-B | Metal surface modification process and application thereof | 上海新能量纳米科技股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-02-03 | — | — | US | disclosed |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2021-11-30 | — | — | US | disclosed |
| CN-112195474-A | Metal surface modification process and application thereof | 上海新能量纳米科技股份有限公司 | 2021-01-08 | — | — | CN | disclosed |
| US-20190330516-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-10-31 | — | — | US | disclosed |
| US-10400156-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-09-03 | — | — | US | disclosed |
| CN-105642185-B | A kind of anionic-cationic-nonionic surface active agent, its manufacturing method and its application | 中国石油化工股份有限公司 | 2018-07-31 | — | — | CN | disclosed |
| US-20170313928-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2017-11-02 | — | — | US | disclosed |
| CN-105642185-A | Anionic-cationic-nonionic surfactant, preparation method therefor and application of anionic-cationic-nonionic surfactant | 中国石油化工股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| EP-1265844-A1 | METHOD FOR PRODUCING AMINES BY THE HYDROAMINOMETHYLATION OF OLEFINS IN THE PRESENCE OF IONIC LIQUIDS | Bayer Aktiengesellschaft (DE) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001064621-A1 | METHOD FOR PRODUCING AMINES BY THE HYDROAMINOMETHYLATION OF OLEFINS IN THE PRESENCE OF IONIC LIQUIDS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-07 | — | — | WO | disclosed |
| EP-0292564-B1 | PROCESS FOR PREPARING ALKOXYALKYL-SUBSTITUTED PHENOLS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4952736-A | REACTING ALKYL PHENOL, ALCOHOL, AND ALDEHYDE IN PRESENCE OF TERTIARY AMINE CATALYST | Idemitsu Petrochmeical Company, Limited (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0292564-A1 | PROCESS FOR PREPARING ALKOXYALKYL-SUBSTITUTED PHENOLS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330516-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | LIPA, ABHD12, ABHD16A | KCNH2 1018/4885MAPT 4196/4885BCHE 1322/4885 |
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, SGMS1, AQP1 | KCNH2 825/4885MAPT 4160/4885BCHE 1940/4885 |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, ABHD12, ABHD16A | KCNH2 1018/4885MAPT 4196/4885BCHE 1322/4885 |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | LIPA, ABHD16A, ABHD12 | KCNH2 1024/4885MAPT 4395/4885BCHE 1247/4885 |
| US-10400156-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, ABHD12, ABHD16A | KCNH2 1018/4885MAPT 4196/4885BCHE 1322/4885 |
| US-20170313928-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF | LIPA, ABHD12, ABHD16A | KCNH2 1018/4885MAPT 4196/4885BCHE 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.